The longevity peptide stack protocol combines three compounds targeting three hallmarks of aging: telomere shortening, immune senescence, and extracellular matrix degradation. Here is the science behind the combination.
The longevity peptide stack protocol brings together three compounds — Epithalon, Thymosin Alpha-1, and GHK-Cu — that target three independent axes of aging: the cellular replicative clock, the immune system, and the structural scaffold of the body.
Replicative senescence occurs when telomeres shorten to a critical point. Epithalon activates telomerase, the enzyme that extends telomeres, in somatic cells. Longevity peptide research in the Bulletin of Experimental Biology has documented telomere elongation and reduction in age-associated inflammation following Epithalon treatment.
Immunosenescence is the progressive decline of T-cell maturation driven by thymic involution. Thymosin Alpha-1 drives the development of functional T-cell subsets and restores cytokine balance in aged immune models, addressing the pro-inflammatory environment that characterizes aging.
The extracellular matrix (ECM) degrades with age as collagen synthesis slows down. GHK-Cu modulates thousands of genes toward tissue remodeling and repair, promoting collagen and elastin synthesis and inhibiting the pathways that break down structural scaffold.
Beyond Health Lab supplies The Longevity Baseline Stack at ≥99% verified purity.
Join 10,000+ researchers. Get your discount code, early access to new compounds, and protocol insights.
No spam, ever. Unsubscribe anytime.
Check your inbox for your discount code.
Here's a preview:
Valid on all products · Single use
